SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 23, 2003
Specialty Laboratories, Inc.
(Exact name of registrant as specified in charter)
|
California |
|
001-16217 |
|
95-2961036 |
|
(State or other
jurisdiction |
|
(Commission |
|
(IRS Employer |
|
2211 Michigan Avenue, Santa Monica, California |
|
90404 |
|
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code (310) 828-6543
(Former name or former address, if changed since last report.)
|
ITEM 7 |
|
FINANCIAL STATEMENTS AND EXHIBITS |
||||
|
|
|
|
|
|
||
|
|
(c) |
|
Exhibits |
|
The following document is filed as an exhibit to this report: |
|
|
|
|
|
|
|
|
|
|
|
|
99.1 |
|
Press Release dated October 23, 2003. |
||
|
|
|
|
|
|
||
|
ITEM 12 |
|
RESULTS OF OPERATIONS AND FINANCIAL CONDITION |
||||
On October 23, 2003, Specialty Laboratories, Inc., (the “Registrant”) announced financial results for the third quarter ended September 30, 2003. A copy of the press release issued by the Registrant on October 23, 2003 concerning the foregoing matter is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
Specialty Laboratories, Inc. |
||
|
|
|
||
|
|
|
||
|
Date: October 23, 2003 |
By: |
/s/ FRANK J. SPINA |
|
|
|
|
Frank J. Spina, |
|
|
|
|
Chief Financial Officer |
|
3
EXHIBIT INDEX
|
Exhibits |
|
The following document is filed as an exhibit to this report: |
|
|
|
|
|
99.1 |
|
Press Release dated October 23, 2003. |
4